However, the test could only predict MS flare-ups out to one year. The test reflects current or recent nerve damage, "which makes it excellent for short-term risk assessment," Martinez-Serrat said.

However, the test could only predict MS flare-ups out to one year. The test reflects current or recent nerve damage, “which makes it excellent for short-term risk assessment," Martinez-Serrat said.

There is no single test that unequivocally detects MS. When faced with a patient whose symptoms, neurological exam results, and medical history suggest MS, physicians use a variety of tools to look ...

The test that was developed using an existing diagnostic procedure as its basis and has the potential to be applied in clinical trials that target the Epstein Barr Virus.

Test results were more likely to influence clinical decision-making when patients received multiple (longitudinal) MSDA tests compared with just one test (69.2% vs 59.8%). However, the impact of ...

The test has the potential to "improve outcomes for MS patients by offering a minimally invasive blood draw that can deliver rapid results," said Matt Sause, CEO of Roche Diagnostics.

Key Takeaways A blood test might predict relapses in MS Neurofilament light chain levels spike in MS patients’ blood before a relapse However, the prediction window is only a year or less ...

Key TakeawaysKey Takeaways A blood test might predict relapses in MS Neurofilament light chain levels spike in MS patients’ blood before a relapse However, the prediction window is only a year ...

However, the test could only predict MS flare-ups out to one year. The test reflects current or recent nerve damage, “which makes it excellent for short-term risk assessment," Martinez-Serrat said.

Key Takeaways A blood test might predict relapses in MSNeurofilament light chain levels spike in MS patients’ blood before a relapseHowever, the prediction window is only a year or less TUESDAY ...